The future of susceptibility contrast for assessment of anatomy and function

NeuroImage

Volumn 62, Issue 2, 2012, Pages 1311-1315

  Reichenbach, Jürgen R ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Magnetic resonance imaging; Magnetic susceptibility; Phase imaging; Quantitative susceptibility mapping; Susceptibility weighted imaging

Indexed keywords

CONTRAST MEDIUM; IRON;

BOLD SIGNAL; BRAIN; BRAIN FUNCTION; BRAIN MAPPING; BRAIN NUCLEUS; CONTRAST ENHANCEMENT; DENATURATION; ECHOGRAPHY; HOMEOSTASIS; HUMAN; IMAGE ANALYSIS; MAGNETISM; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; STRUCTURE ANALYSIS; SUSCEPTIBILITY WEIGHTED IMAGING; TISSUE CHARACTERIZATION; TISSUE STRUCTURE; WHITE MATTER;

ANIMALS; BRAIN; BRAIN MAPPING; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETICS;

EID: 84862981664     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.01.004     Document Type: Review

References (82)

1. Abdul-Rahman H.S., Gdeisat M.A., Burton D.R., Lalor M.J., Lilley F., Moore C.J. Fast and robust three-dimensional best path phase unwrapping algorithm. Appl. Opt. 2007, 46:6623-6635.
2. Barth M., Diemling M., Moser E. Modulation of signal changes in gradient-recalled echo functional MRI with increasing echo time correlate with model calculations. Magn. Reson. Imaging 1997, 15:745-752.
3. Bouras C., Giannakopoulos P., Good P.F., Hsu A., Hof P.R., Perl D.P. A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease. Eur. Neurol. 1997, 38:53-58.
4. 2*-, phase-, and susceptibility-weighted contrast. Magn. Reson. Med. 2011, 65:544-550.
5. Chen J.C., Hardy P.A., Kucharczyk W., Clauberg M., Joshi J.G., Vourlas A., Dhar M., Henkelman R.M. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am. J. Neuroradiol. 1993, 14:275-281.
6. Cheng Y.C., Neelavalli J., Haacke E.M. Limitations of calculating field distributions and magnetic susceptibilities in MRI using a Fourier based method. Phys. Med. Biol. 2009, 54:1169-1189.
7. de Rochefort L., Brown R., Prince M.R., Wang Y. Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field. Magn. Reson. Med. 2008, 60:1003-1009.
8. de Rochefort L., Nguyen T., Brown R., Spincemaille P., Choi G., Weinsaft J., Prince M.R., Wang Y. In vivo quantification of contrast agent concentration using the induced magnetic field for time-resolved arterial input function measurement with MRI. Med. Phys. 2008, 35:5328-5339.
9. de Rochefort L., Liu T., Kressler B., Liu J., Spincemaille P., Lebon V., Wu J., Wang Y. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn. Reson. Med. 2010, 63:194-206.
10. Deistung A., Rauscher A., Sedlacik J., Stadler J., Witoszynskyj S., Reichenbach J.R. Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn. Reson. Med. 2008, 60:1155-1168.
11. Deistung A., Lehr B., Schweser F., Reichenbach J.R. Calculation of the magnetic susceptibility from susceptibility weighted phase images. Proc. Int. Soc. Magn. Reson. Med. 2009, 17. (#2931).
12. Deistung A., Dittrich E., Sedlacik J., Rauscher A., Reichenbach J.R. ToF-SWI: simultaneous time of flight and fully flow compensated susceptibility weighted imaging. J. Magn. Reson. Imaging 2009, 29:1478-1484.
13. 3He. Phys. Rev. B 1979, 19:5666-5688.
14. Dexter D.T., Carayon A., Javoy-Agid F., Agid Y., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991, 114:1953-1975.
15. Duyn J.H., van Gelderen P., Li T.Q., de Zwart J.A., Koretsky A.P., Fukunaga M. High-field MRI of brain cortical substructure based on signal phase. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:11796-11801.
16. Feng Z., Caprihan A., Blagoev K.B., Calhoun V.D. Biophysical modeling of phase changes in BOLD fMRI. NeuroImage 2009, 47:540-548.
17. Fukunaga M., Li T.Q., van Gelderen P., de Zwart J.A., Shmueli K., Yao B., Lee J., Maric D., Aronova M.A., Zhang G., Leapman R.D., Schenck J.F., Merkle H., Duyn J.H. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3834-3839.
18. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B. Altered brain metabolism of iron as a cause of neurodegenerative diseases?. J. Neurochem. 1994, 63:793-807.
19. Haacke E.M., Ye Y. The role of susceptibility weighted imaging in functional MRI. Neuroimage 2012, 62:922-928. (this issue).
20. Haacke E.M., Reichenbach J.R. Susceptibility Weighted Imaging in MRI: Basic Concepts and Clinical Applications 2011, Wiley-Blackwell, Hoboken, NJ.
21. Haacke E.M., Xu Y., Cheng Y.C., Reichenbach J.R. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 2004, 52:612-618.
22. Haacke E.M., Tang J., Neelavalli J., Cheng Y.C. Susceptibility mapping as a means to visualize veins and quantify oxygen saturation. J. Magn. Reson. Imaging 2010, 33:663-676. (Erratum in: J. Magn. Reson. Imaging 2011. 33, 1527-1529).
23. Hallgren B., Sourander P. The non-haemin iron in the cerebral cortex in Alzheimer's disease. J. Neurochem. 1960, 5:307-310.
24. He X., Yablonskiy D.A. Biophysical mechanisms of phase contrast in gradient echo MRI. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13558-13563.
25. Höck A., Demmel U., Schicha H., Kasperek K., Feinendegen L.E. Trace element concentration in human brain. Activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium. Brain 1975, 98:49-64.
26. Holt R.W., Diaz P.J., Duerk J.L., Bellon E.M. MR susceptometry: an external-phantom method for measuring bulk susceptibility from field-echo phase reconstruction maps. J. Magn. Reson. Imaging 1994, 4:809-818.
27. Hopp K., Popescu B.F., McCrea R.P., Harder S.L., Robinson C.A., Haacke M.E., Rajput A.H., Rajput A., Nichol H. Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence. J. Magn. Reson. Imaging 2010, 31:1346-1354.
28. Jenkinson M. Fast, automated, N-dimensional phase-unwrapping algorithm. Magn. Reson. Med. 2003, 49:193-197.
29. Ke Y., Qian Z. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol. 2003, 2:246-253.
30. Koch K.M., Papademetris X., Rothman D.L., de Graaf R.A. Rapid calculations of susceptibility-induced magnetostatic field perturbations for in vivo magnetic resonance. Phys. Med. Biol. 2006, 51:6381-6402.
31. Koopmans P.J., Manniesing R., Niessen W.J., Viergever M.A., Barth M. MR venography of the human brain using susceptibility weighted imaging at very high field strength. Magn. Reson. Mater. Phys. (MAGMA) 2008, 21:149-158.
32. Kressler B., de Rochefort L., Liu T., Spincemaille P., Jiang Q., Wang Y. Nonlinear regularization for per voxel estimation of magnetic susceptibility distributions from MRI field maps. IEEE Trans. Med. Imaging 2010, 29:273-281.
33. Lai S., Reichenbach J.R., Haacke E.M. Commutator filter: a novel technique for the identification of structures producing significant susceptibility inhomogeneities and its application to functional MRI. Magn. Reson. Med. 1996, 36:781-787.
34. Laule C., Vavasour I.M., Kolind S.H., Li D.K., Traboulsee T.L., Moore G.R., MacKay A.L. Magnetic resonance imaging of myelin. Neurotherapeutics 2007, 4:460-484.
35. Lee J., Shmueli K., Kang B.T., Yao B., Fukunaga M., van Gelderen P., Palumbo S., Bosetti F., Silva A.C., Duyn J.H. The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain. NeuroImage 2011, 2011 Oct 29 (Electronic publication ahead of print) PMID:22056461.
36. LeVine S.M. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 1997, 760:298-303.
37. Li L. Magnetic susceptibility quantification for arbitrarily shaped objects in inhomogeneous field. Magn. Reson. Med. 2001, 46:907-916.
38. Li L., Leigh J.S. Quantifying arbitrary magnetic susceptibility distributions with MR. Magn. Reson. Med. 2004, 51:1077-1082.
39. Li W., Wu B., Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. NeuroImage 2011, 55:1645-1656.
40. Li W., Wu B., Avram A.V., Liu C. Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinnings. NeuroImage 2012, 59:2088-2097.
41. Liu C. Susceptibility tensor imaging. Magn. Reson. Med. 2010, 63:1471-1477.
42. Liu T., Spincemaille P., de Rochefort L., Kressler B., Wang Y. Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI. Magn. Reson. Med. 2009, 61:196-204.
43. Liu T., Spincemaille P., de Rochefort L., Wong R., Prince M., Wang Y. Unambiguous identification of superparamagnetic iron oxide particles through quantitative susceptibility mapping of the nonlinear response to magnetic fields. Magn. Reson. Imaging 2010, 28:1383-1389.
44. Liu T., Liu J., de Rochefort L., Spincemaille P., Khalidov I., Ledoux J.R., Wang Y. Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: comparison with COSMOS in human brain imaging. Magn. Reson. Med. 2011, 66:777-783.
45. Liu T., Khalidov I., de Rochefort L., Spincemaille P., Liu J., Tsiouris A.J., Wang Y. A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed. 2011, 24:1129-1136.
46. Liu C., Li W., Johnson G.A., Wu B. High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. NeuroImage 2011, 56(3):930-938.
47. Liu C., Li W., Wu B., Jiang Y., Johnson G.A. 3D fiber tractography with susceptibility tensor imaging. NeuroImage 2012, 59:1290-1298.
48. 1H MR frequency shifts: contributions from magnetic susceptibility and exchange effects. J. Magn. Reson. 2010, 202:102-108.
49. Marques J.P., Bowtell R. Application of a Fourier-based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility. Concepts Magn. Reson. 2005, 25B:65-78.
50. Marques J.P., van der Zwaag W., Granziera C., Krüger G., Grütter R. Cerebellar cortical layers: in vivo visualization with structural high-field-strength MR imaging. Radiology 2010, 254:942-948.
51. Morris C.M., Candy J.M., Oakley A.E., Bloxham C.A., Edwardson J.A. Histochemical distribution of non-haem iron in the human brain. Acta Anat. (Basel) 1992, 144:235-257.
52. Ogawa S., Lee T.M., Kay A.R., Tank D.W. Brain magnetic-resonance-imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:9868-9872.
53. Petridou N., Schäfer A., Gowland P., Bowtell R. Phase vs. magnitude information in functional magnetic resonance imaging time series: toward understanding the noise. Magn. Reson. Imaging 2009, 27:1046-1057.
54. Pinero D.J., Connor J.R. Iron in the brain: an important contributor in normal and diseased states. Neuroscientist 2000, 6:435-453.
55. Popescu B.F., Nichol H. Mapping brain metals to evaluate therapies for neurodegenerative disease. CNS Neurosci. Ther. 2011, 17:256-268.
56. Prudent V., Kumar A., Liu S., Wiggins G., Malaspina D., Gonen O. Human hippocampal subfields in young adults at 7.0 T: feasibility of imaging. Radiology 2010, 254:900-906.
57. Rauscher A., Sedlacik J., Barth M., Mentzel H.J., Reichenbach J.R. Magnetic susceptibility weighted MR phase imaging of the human brain. AJNR Am. J. Neuroradiol. 2005, 26:736-742.
58. Rauscher A., Sedlacik J., Barth M., Haacke E.M., Reichenbach J.R. Noninvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging. Magn. Reson. Med. 2005, 54:87-95.
59. Reichenbach J.R., Haacke E.M. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed. 2001, 14:453-467.
60. Reichenbach J.R., Venkatesan R., Yablonskiy D.A., Thompson M.R., Lai S., Haacke E.M. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J. Magn. Reson. Imaging 1997, 7:266-279.
61. Reichenbach J.R., Venkatesan R., Schillinger D.J., Kido D.K., Haacke E.M. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997, 204:272-277.
62. Rowe D.B. Modeling both the magnitude and phase of complex-valued fMRI data. NeuroImage 2005, 25:1310-1324.
63. Salomir R., de Senneville B.D., Moonen C.T.W. A fast calculation method for magnetic field inhomogeneity due to an arbitrary distribution of susceptibility. Concepts Magn. Reson. 2003, 19B:26-34.
64. Schäfer A., Wharton S., Gowland P., Bowtell R. Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI. NeuroImage 2009, 48:126-137.
65. Schweser F., Deistung A., Lehr B.W., Reichenbach J.R. Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med. Phys. 2010, 37:5165-5178.
66. Schweser F., Hütten M., Lehr B.W., Deistung A., Güllmar D., Reichenbach J.R. Resolving phase: inversion of SWI-phase data in order to obtain its sources utilizing the concept of generalized Lorentzian approximation. Proc. Int. Soc. Magn. Reson. Med. 2010, 18. (#5003).
67. Schweser F., Deistung A., Lehr B.W., Reichenbach J.R. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?. NeuroImage 2011, 54:2789-2807.
68. 2*-weighted imaging sequence. Proc. Int. Soc. Magn. Reson. Med. 2011, 19. (#120).
69. Sedlacik J., Rauscher A., Reichenbach J.R. Obtaining blood oxygenation levels from MR signal behavior in the presence of single venous vessels. Magn. Reson. Med. 2007, 58:1035-1044.
70. Sedlacik J., Helm K., Rauscher A., Stadler J., Mentzel H.J., Reichenbach J.R. Investigations on the effect of caffeine on cerebral venous vessel contrast by using susceptibility-weighted imaging (SWI) at 1.5, 3 and 7T. NeuroImage 2008, 40:11-18.
71. Sedlacik J., Kutschbach C., Rauscher A., Deistung A., Reichenbach J.R. Investigation of the influence of carbon dioxide concentrations on cerebral physiology by susceptibility-weighted magnetic resonance imaging (SWI). NeuroImage 2008, 43:36-43.
72. Shmueli K., de Zwart J.A., van Gelderen P., Li T.Q., Dodd S.J., Duyn J.H. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn. Reson. Med. 2009, 62:1510-1522.
73. Shmueli K., Dodd S.J., Li T.Q., Duyn J.H. The contribution of chemical exchange to MRI frequency shifts in brain tissue. Magn. Reson. Med. 2011, 65:35-43.
74. Vavasour I.M., Laule C., Li D.K., Traboulsee A.L., MacKay A.L. Is the magnetization transfer ratio a marker for myelin in multiple sclerosis?. J. Magn. Reson. Imaging 2011, 33:713-718.
75. Wang B., Wang Z., Feng W., Wang M., Hu Z., Chai Z., Zhao Y. New methods for nanotoxicology: synchrotron radiation-based techniques. Anal. Bioanal. Chem. 2010, 398:667-676.
76. Wharton S., Bowtell R. Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods. NeuroImage 2010, 53:515-525.
77. Wharton S., Bowtell R. A four parameter fitting method to quantify fully the sources of phase contrast in gradient echo MRI. Proc. Int. Soc. Magn. Reson. Med. 2011, 19. (#2762).
78. Wharton S., Schäfer A., Bowtell R. Susceptibility mapping in the human brain using threshold-based k-space division. Magn. Reson. Med. 2010, 63:1292-1304.
79. Witoszynskyj S., Rauscher A., Reichenbach J.R., Barth M. Phase unwrapping of MR images using ΦUN-a fast and robust region growing algorithm. Med. Image Anal. 2009, 13:257-268.
80. Wu B., Li W., Guidon A., Liu C. Whole brain susceptibility mapping using compressed sensing. Magn. Reson. Med. 2012, 67:137-147.
81. Zhao F., Jin T., Wang P., Hu X., Kim S.G. Sources of phase changes in BOLD and CBV-weighted fMRI. Magn. Reson. Med. 2007, 57:520-527.
82. Zhong K., Leupold J., von Elverfeldt D., Speck O. The molecular basis for gray and white matter contrast in phase imaging. NeuroImage 2008, 40:1561-1566.